Thursday, July 30

Healthcare

Alnylam tumbles, BridgeBio gains after heart drug data

09/01/20241 Min Read

Alnylam BridgeBio data drug gains heart tumbles

Previous ArticleNovavax gains on FDA emergency nod for updated COVID shot

Next Article Align to pay $27.5M to SmileDirectClub clients as antitrust lawsuit nears settlement